Domestic anti-impotence drugs market getting intensified

Published: 2002-03-29 06:58:00

Updated: 2002-03-29 06:58:00

Stimulated by the increasing interest in sexual dysfunction, five domestic firms (Bayer Korea, Shinpoong Pharm, Lilly Korea, Hwanin Pharm and Dong-A Pharm) are likely to launch their anti-impotence drugs with diverse dosage forms such as injection, tablet and topical ointment. Competition over th...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK